[Metabolic disorders induced by a combination of sodium gamma-hydroxybutyrate and tetracosactide in head-injury patients].
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives*; D003366:Cosyntropin / Q000009:adverse effects*; D006259:Craniocerebral Trauma / Q000188:drug therapy* / Q000378:metabolism; D004359:Drug Therapy, Combination; D006801:Humans; D006885:Hydroxybutyrates / Q000009:adverse effects*; D008297:Male; D008659:Metabolic Diseases / Q000139:chemically induced*; D008875:Middle Aged; D012978:Sodium Oxybate / Q000009:adverse effects*
D006885:Hydroxybutyrates; D003366:Cosyntropin; D012978:Sodium Oxybate; D000324:Adrenocorticotropic Hormone
Troubles métaboliques induits par l'association gamma-hydroxybutyrate de sodium et tétracosactide chez le traumatisé crânien.